Novartis hands $16 million Voltaren Emulgel account to Starcom in China

BEIJING - Swiss pharmaceutical giant Novartis is believed to have handed its Voltaren Emulgel brand's media account to Starcom in China following a competitive three-way pitch that included ZenithOptimedia and MEC.

by Kenny Lim

Please sign in below or access limited articles a month after free, fast registration.

 If you don’t yet have an account, you can register for free to unlock additional content. For full access to everything we offer, view our subscription plans.

Register for free

✓ Access limited free articles each month

✓ Email bulletins – top industry news and insights delivered straight to your inbox

Register now

Subscribe

✓ Unlimited access to all Campaign Asia content

✓ Real-world campaign case studies and career insights

✓ Exclusive reports, industry news, and annual features

Join now